Jump to content
Sclero Forums

Search the Community

Showing results for tags 'bowel dysfunction'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Worldwide
    • Welcome: Guidelines and FAQs
    • Sclero Forums (MAIN)
    • UK Scleroderma
    • News
    • Personal Support

Blogs

  • CFM Babs from Chorley FM
  • barefut impressions
  • My Two Cents...
  • Amanda Thorpe's Blog
  • Joelf's Blog
  • Michael Thorpe's Blog

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


Location

Found 14 results

  1. The association between irritable bowel syndrome and osteoporosis: a systematic review and meta-analysis. A significantly increased risk of osteoporosis among IBS patients was observed in this study. PubMed, Osteoporos Int, 02/01/2020. (Also see Bowel Dysfunction and Osteoporosis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  2. Colonic Manifestations and Complications Are Relatively Under-Reported in Systemic Sclerosis (SSc): A Systematic Review. Colonic complications comprise a large proportion of the published reports on gastrointestinal symptoms afflicting patients with Ssc. PubMed, Am J Gastroenterol, 2019 Dec;114(12):1847-1856. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  3. The Relationship Between Autonomic Dysfunction of the Gastrointestinal (GI) Tract and Emotional Distress in Patients With Systemic Sclerosis (SSc). In SSc, increased symptom burden related to GI dysautonomia is associated with emotional distress. PubMed, J Clin Rheumatol, 09/12/2019. (Also see Bowel Dysfunction and Coping with Scleroderma) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  4. Colonic and Anorectal Manifestations of Systemic Sclerosis. Colonic and anorectal manifestations of systemic sclerosis include constipation, diarrhea, and fecal incontinence, and can diminish quality of life for these patients. PubMed, Curr Gastroenterol Rep, 2019 Jul 8;21(7):33. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  5. Gut bacteria may have motor neurone disease role. Gut bacteria may be playing a role in motor neurone disease, according to early studies in animals and people. BBC Health News, 07/22/2019. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  6. Prevalence and associated factors of small intestinal bacterial overgrowth (SIBO) among systemic sclerosis (SSc) patients. The prevalence of SIBO, using the glucose H2 /CH4 breath test, is not common, however a positive result was associated with longer duration of disease. PubMed, Int J rheumatologist Dis, 02/06/2019. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  7. Treatment of small intestinal bacterial overgrowth (SIBO) in systemic sclerosis (SSc): a systematic review. For some SSc patients, antibiotics can eradicate SIBO and there is a paucity of data reporting the effectiveness of either prokinetics or probiotics in SSc. PubMed, Rheumatology (Oxford), 07/02/2018. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  8. Microbial and metabolic multi–omic correlations in systemic sclerosis (SSc) patients. Our data suggest that in SSc, intestinal microbiota is characterized by proinflammatory alterations subtly entwined with the metabolic state. PubMed, Ann N Y Acad Sci, 05/11/2018. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  9. Intestinal microbiome in scleroderma (SSc): recent progress. Emerging evidence suggests that alterations in gut microbiota exist in the SSc disease state and more studies are needed to ascertain the mechanism by which these alterations perpetuate inflammation and fibrosis in SSc. PubMed, Curr Opin Rheumatol, 2017 Nov;29(6):553-560. (Also see Bowel Dysfunction and Endocannabinoid System) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  10. Intestinal microbiome in scleroderma (SSC): recent progress. Therapeutic trials are needed to investigate whether dietary interventions or fecal transplantation can restore the gut microbial balance and improve health outcomes in SSc. PubMed, Curr Opin Rheumatol, 07/15/2017. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  11. Systemic sclerosis (SSc) is associated with specific alterations in gastrointestinal microbiota in two independent cohorts. These findings suggest that gastrointestinal tract dysbiosis may be a pathological feature of the SSc disease state. BMJ Open Gastro, 2017; 4:e000134. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  12. Clinical correlates of faecal incontinence (FI) in systemic sclerosis (SSc): identifying therapeutic avenues. Other than targeting anorectal dysfunction, concomitant treatment of clinical correlates could lead to improvement in FI and quality of life in SSc. PubMed, Rheumatology (Oxford), 12/24/2016. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  13. Lactose malabsorption in systemic sclerosis. Our findings highlight the fact that lactose breath test is a helpful, non–invasive method, by identifying the group of patients with systemic sclerosis with symptomatic lactose malabsorption that may benefit from a reduction in lactose intake. PubMed, Aliment Pharmacol Ther, 2016 Nov;44(10):1123-1133. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  14. Intestinal dysbiosis is common in systemic sclerosis (SSc) and associated with gastrointestinal and extraintestinal features of disease. Intestinal dysbiosis was common in patients with SSc and was associated with gastrointestinal dysfunction, malnutrition and with some inflammatory, fibrotic and vascular extraintestinal features of SSc. PubMed, Arthritis Res Ther, 2016 Nov 29;18(1):278. (Also see Bowel Dysfunction) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
×
×
  • Create New...